Key terms
About ACHV
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ACHV news
Yesterday
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 28, 2024
Mar 25
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
Mar 20
8:07am ET
Achieve Life Sciences announces data from cytisinicline ORCA program
Mar 05
9:00am ET
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), ClearPoint Neuro (CLPT)
Mar 05
8:41am ET
Achieve Life Sciences price target lowered to $11 from $19 at Lake Street
Feb 29
4:52pm ET
Achieve Life Sciences Raises Funds for Clinical Trials
Feb 29
2:15pm ET
Buy Rating for Achieve Life Sciences on Cytisinicline’s Promising Future and Solid Financials
Feb 29
8:29am ET
Achieve Life reaches agreement with FDA on cytisinicline data requirements
Feb 29
8:22am ET
Achieve Life Sciences sells 13M shares at $4.585 in registered direct offering
No recent news articles are available for ACHV
No recent press releases are available for ACHV
ACHV Financials
Key terms
Ad Feedback
ACHV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ACHV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range